Pathogenesis of murine cytomegalovirus infection.

[1]  P. Klenerman,et al.  Memory Inflation: Continous Accumulation of Antiviral CD8+ T Cells Over Time , 2003, The Journal of Immunology.

[2]  L. Lanier,et al.  NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.

[3]  U. Koszinowski,et al.  Role of Murine Cytomegalovirus US22 Gene Family Members in Replication in Macrophages , 2003, Journal of Virology.

[4]  R. Salomon,et al.  Dendritic Cell Responses to Early Murine Cytomegalovirus Infection , 2003, The Journal of experimental medicine.

[5]  R. Dix,et al.  Loss of the Perforin Cytotoxic Pathway Predisposes Mice to Experimental Cytomegalovirus Retinitis , 2003, Journal of Virology.

[6]  P. Klenerman,et al.  Regulation of the Class II MHC Pathway in Primary Human Monocytes by Granulocyte-Macrophage Colony-Stimulating Factor 1 , 2003, The Journal of Immunology.

[7]  Susan M. Kaech,et al.  Molecular and Functional Profiling of Memory CD8 T Cell Differentiation , 2002, Cell.

[8]  M. Reddehase.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance , 2002, Nature Reviews Immunology.

[9]  D. Fremont,et al.  Cutting Edge: Murine UL16-Binding Protein-Like Transcript 1: A Newly Described Transcript Encoding a High-Affinity Ligand for Murine NKG2D1 , 2002, The Journal of Immunology.

[10]  M. Okabe,et al.  Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV‐responsive element in the CD46 promoter region , 2002, European journal of immunology.

[11]  A. Scalzo.  Successful control of viruses by NK cells--a balance of opposing forces? , 2002, Trends in microbiology.

[12]  U. Koszinowski,et al.  Major Histocompatibility Complex Class I Allele-specific Cooperative and Competitive Interactions between Immune Evasion Proteins of Cytomegalovirus , 2002, The Journal of experimental medicine.

[13]  A. N. van den Pol,et al.  Enhanced Cytomegalovirus Infection of Developing Brain Independent of the Adaptive Immune System , 2002, Journal of Virology.

[14]  S. Atherton,et al.  Apoptosis in the retina during MCMV retinitis in immunosuppressed BALB/c mice. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  M. Reddehase,et al.  Mouse models of cytomegalovirus latency: overview. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  M. Abecassis,et al.  A model for reactivation of CMV from latency. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  D. Fremont,et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Fairweather,et al.  Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. , 2002, Journal of molecular and cellular cardiology.

[19]  D. Busch,et al.  MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo , 2002, Nature Immunology.

[20]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[21]  M. Reddehase,et al.  Two Antigenic Peptides from Genes m123 and m164 of Murine Cytomegalovirus Quantitatively Dominate CD8 T-Cell Memory in the H-2d Haplotype , 2002, Journal of Virology.

[22]  U. Koszinowski,et al.  The Multiple Immune-Evasion Genes of Murine Cytomegalovirus Are Not Redundant , 2001, The Journal of experimental medicine.

[23]  M. Reddehase,et al.  Experimental Preemptive Immunotherapy of Murine Cytomegalovirus Disease with CD8 T-Cell Lines Specific for ppM83 and pM84, the Two Homologs of Human Cytomegalovirus Tegument Protein ppUL83 (pp65) , 2001, Journal of Virology.

[24]  Raymond M. Welsh,et al.  Murine Cytomegalovirus Is Regulated by a Discrete Subset of Natural Killer Cells Reactive with Monoclonal Antibody to Ly49h , 2001, The Journal of experimental medicine.

[25]  T. Chittenden,et al.  A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Chilakamarti V. Ramana,et al.  Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Shixian Yan,et al.  Allogeneic Transplantation Induces Expression of Cytomegalovirus Immediate-Early Genes In Vivo: a Model for Reactivation from Latency , 2001, Journal of Virology.

[28]  Jonathan W. Heusel,et al.  Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection , 2001, Science.

[29]  Seung-Hwan Lee,et al.  Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily , 2001, Nature Genetics.

[30]  D. Sedmak,et al.  Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression. , 2001, Seminars in immunology.

[31]  J. Heesemann,et al.  A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. , 2001, Science.

[32]  M. Reddehase,et al.  Enrichment of Immediate-Early 1 (m123/pp89) Peptide-Specific CD8 T Cells in a Pulmonary CD62Llo Memory-Effector Cell Pool during Latent Murine Cytomegalovirus Infection of the Lungs , 2000, Journal of Virology.

[33]  A. Alcamí,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[34]  P. Doherty,et al.  Quantitative analysis of the CD8+ T-cell response to readily eliminated and persistent viruses. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  M. Reddehase,et al.  Murine Model of Interstitial Cytomegalovirus Pneumonia in Syngeneic Bone Marrow Transplantation: Persistence of Protective Pulmonary CD8-T-Cell Infiltrates after Clearance of Acute Infection , 2000, Journal of Virology.

[36]  N. Shastri,et al.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.

[37]  T. Mcclanahan,et al.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. , 2000, Immunity.

[38]  G. Geginat,et al.  The Putative Natural Killer Decoy Early Genem04 (gp34) of Murine Cytomegalovirus Encodes an Antigenic Peptide Recognized by Protective Antiviral CD8 T Cells , 2000, Journal of Virology.

[39]  S. Jonjić,et al.  The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 Protects the Virus against T Cell Control in Vivo , 1999, The Journal of experimental medicine.

[40]  E. Kieff,et al.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Kurz,et al.  Patchwork Pattern of Transcriptional Reactivation in the Lungs Indicates Sequential Checkpoints in the Transition from Murine Cytomegalovirus Latency to Recurrence , 1999, Journal of Virology.

[42]  M. Smyth,et al.  M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection , 1999, The Journal of experimental medicine.

[43]  M. Degli-Esposti,et al.  The Murine Cytomegalovirus Chemokine Homolog, m131/129, Is a Determinant of Viral Pathogenicity , 1999, Journal of Virology.

[44]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[45]  E. Mocarski,et al.  Quantitative Analysis of Latent Human Cytomegalovirus , 1999, Journal of Virology.

[46]  S. Jonjić,et al.  Cytomegaloviral control of MHC class I function in the mouse , 1999, Immunological reviews.

[47]  U. Koszinowski,et al.  A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.

[48]  D. Kaufman,et al.  Immunosuppression is not required for reactivation of latent murine cytomegalovirus. , 1999, Transplantation proceedings.

[49]  P. Angele,et al.  Control of Cytomegalovirus in Bone Marrow Transplantation Chimeras Lacking the Prevailing Antigen-Presenting Molecule in Recipient Tissues Rests Primarily on Recipient-Derived CD8 T Cells , 1998, Journal of Virology.

[50]  S. Jonjić,et al.  Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection , 1998, The Journal of experimental medicine.

[51]  M. Reddehase,et al.  Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. , 1998, The Journal of general virology.

[52]  P. Angele,et al.  Cytomegalovirus Inhibits the Engraftment of Donor Bone Marrow Cells by Downregulation of Hemopoietin Gene Expression in Recipient Stroma , 1998, Journal of Virology.

[53]  M. Heise,et al.  Murine Cytomegalovirus Inhibits Interferon γ–induced Antigen Presentation to CD4 T Cells by Macrophages Via Regulation of Expression of Major Histocompatibility Complex Class II–associated Genes , 1998, The Journal of experimental medicine.

[54]  E. Mocarski,et al.  Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Sedmak,et al.  Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway , 1998, The Journal of experimental medicine.

[56]  S. Jonjić,et al.  Virus Attenuation after Deletion of the Cytomegalovirus Fc Receptor Gene Is Not due to Antibody Control , 1998, Journal of Virology.

[57]  J. Orange,et al.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection , 1997, Journal of virology.

[58]  U. Koszinowski,et al.  Interference with antigen processing by viruses. , 1997, Current opinion in immunology.

[59]  P. Angele,et al.  Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes , 1997, Journal of virology.

[60]  H. Vally,et al.  Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo , 1997, Nature.

[61]  J. Harris,et al.  Latency versus Persistence or Intermittent Recurrences : Evidence for a Latent State of Murine Cytomegalovirus in the Lungs , 1996 .

[62]  H. Ploegh,et al.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface , 1997, The EMBO journal.

[63]  B. Barrell,et al.  Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus , 1997, Journal of virology.

[64]  H. Virgin,et al.  Late expression of a beta chemokine homolog by murine cytomegalovirus , 1997, Journal of virology.

[65]  R. Welsh,et al.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells , 1997, Journal of virology.

[66]  P. Price,et al.  Adrenalitis and the adrenocortical response of resistant and susceptible mice to acute murine cytomegalovirus infection , 1996, European journal of clinical investigation.

[67]  S. Jonjić,et al.  Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. , 1996, The Journal of general virology.

[68]  U. Koszinowski,et al.  Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. , 1995, The Journal of general virology.

[69]  H. Virgin,et al.  Latency, without persistence, of murine cytomegalovirus in the spleen and kidney , 1995, Journal of virology.

[70]  E. Mocarski,et al.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  U. Koszinowski,et al.  Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor , 1994, Journal of virology.

[72]  P. Lučin,et al.  The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. , 1994, The Journal of general virology.

[73]  Peter C. Doherty,et al.  Virus-specific CD8+ T-cell memory determined by clonal burst size , 1994, Nature.

[74]  S. Jonjić,et al.  Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus , 1994, The Journal of experimental medicine.

[75]  S. Jonjić,et al.  The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease , 1994, The Journal of experimental medicine.

[76]  S. Jonjić,et al.  Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape , 1994, Journal of virology.

[77]  S. Jonjić,et al.  Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. , 1993, The Journal of general virology.

[78]  M. Messerle,et al.  Lungs are a major organ site of cytomegalovirus latency and recurrence , 1993, Journal of virology.

[79]  J. Shanley,et al.  Acute murine cytomegalovirus infection induces lethal hepatitis. , 1993, The Journal of infectious diseases.

[80]  R. Burton,et al.  The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. , 1992, Journal of immunology.

[81]  S. Riddell,et al.  Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. , 1992, Science.

[82]  S. Jonjić,et al.  Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands , 1992, Journal of virology.

[83]  W. Reed,et al.  Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. , 1992, Immunology.

[84]  R. Welsh,et al.  Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function , 1991, The Journal of experimental medicine.

[85]  U. Koszinowski,et al.  Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma , 1991, Journal of virology.

[86]  S. Jonjić,et al.  Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes , 1990, Journal of virology.

[87]  W. Britt,et al.  Congenital and perinatal cytomegalovirus infections. , 1990, Reviews of infectious diseases.

[88]  A. Scalzo,et al.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen , 1990, The Journal of experimental medicine.

[89]  J. Papadimitriou,et al.  Cytomegalovirus-induced pneumonitis and myocarditis in newborn mice , 1990, Archives of Virology.

[90]  A. Campbell,et al.  Murine cytomegalovirus-induced suppression of antigen-specific cytotoxic T lymphocyte maturation. , 1989, Virology.

[91]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[92]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[93]  U. Koszinowski,et al.  Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host , 1988, The Journal of experimental medicine.

[94]  E. J. Wilson,et al.  Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection. , 1986, The American journal of pathology.

[95]  S. Jonjić,et al.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs , 1985, Journal of virology.

[96]  B. Woda,et al.  Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice , 1984, Journal of virology.

[97]  M. Tapper,et al.  Adrenal necrosis in the acquired immunodeficiency syndrome. , 1984, Annals of internal medicine.

[98]  D. Katzenstein,et al.  Lethal infection with murine cytomegalovirus after early viral replication in the spleen. , 1983, The Journal of infectious diseases.

[99]  J. Osborn,et al.  Immunosuppression during acute murine cytomegalovirus infection. , 1968, Journal of immunology.

[100]  S. Riddell,et al.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. , 2001, Nature immunology.

[101]  S. Jonjić,et al.  Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus , 2000, Archives of Virology.

[102]  É. Gönczöl,et al.  Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. , 1998, Cell adhesion and communication.

[103]  U. Koszinowski,et al.  A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.

[104]  S. Jonjić,et al.  Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. , 1994, The Journal of general virology.

[105]  D. Thomas.  Viruses and the cellular immune response , 1993 .

[106]  S. Jonjić,et al.  Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors , 1988, Journal of Virology.

[107]  V. Georgiev.  Virology , 1955, Nature.

[108]  A. O'Guin,et al.  Interferon γ Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels , 1998, The Journal of Experimental Medicine.